arrow_back Trending Legislation
Share share

Easier Genetic Diagnosis for Children via Whole Genome Sequencing

This act aims to facilitate states' access to genetic testing (whole genome sequencing) for children with undiagnosed or suspected genetic diseases under the Medicaid program. This allows children and their parents to receive a quicker diagnosis, potentially improving their treatment and quality of life. States opting to implement these services will receive increased financial support from the federal government.
Key points
Children under 21 (or younger, depending on the state) with suspected genetic conditions can access advanced genetic testing (whole genome sequencing) through Medicaid.
The federal government will cover 75% of these testing costs for the first three years, encouraging states to adopt them.
Hospitals will be required to refer children with undiagnosed issues to qualified whole genome sequencing providers.
The goal is faster diagnosis and better treatment for children with rare or undiagnosed genetic diseases.
article Official text account_balance Process page notifications_active Track this Bill
gavel
Status:
Expired
Record your position for audit.
Why does your vote on bills matter?
It creates raw, undeniable proof. Civic Will provides the permanent data to verify the Government's loyalty towards its citizens (explained here). Start recording it now.
Additional Information
Ending the Diagnostic Odyssey Act of 2021
Print number: S 2022
Sponsor: Sen. Collins, Susan M. [R-ME]
Process start date: 2021-06-10